Fabry disease: genes and variants
Explore variant evidence for Fabry disease across 1 analyzed protein (GLA). Linked ClinVar records include 320 pathogenic or likely pathogenic variants, 198 variants of uncertain significance and 63 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Fabry disease
GLA: Alpha-galactosidase A
It removes terminal alpha-galactose residues from glycosphingolipids during lysosomal degradation. Loss-of-function variants cause Fabry disease, with progressive accumulation of globotriaosylceramide-related lipids in vascular, renal, cardiac, and nervous tissues.
320 ClinVar pathogenic / likely pathogenic and 261 uncertain variants in GLA have source records linked to Fabry disease. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Fabry disease
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| GLA A37P | 37 | Pathogenic / likely pathogenic (★★) | |
| GLA P40S | 40 | Pathogenic / likely pathogenic (★★) | |
| GLA P40L | 40 | Pathogenic / likely pathogenic (★★) | |
| GLA M42I | 42 | Pathogenic / likely pathogenic (★★) | |
| GLA M42V | 42 | Pathogenic / likely pathogenic (★★) | |
| GLA G43R | 43 | Pathogenic / likely pathogenic (★★) | |
| GLA G43V | 43 | Pathogenic / likely pathogenic (★★) | |
| GLA G43S | 43 | Pathogenic / likely pathogenic (★★) | |
| GLA R49S | 49 | Pathogenic / likely pathogenic (★★) | |
| GLA C52R | 52 | Pathogenic / likely pathogenic (★★) | |
| GLA C52G | 52 | Pathogenic / likely pathogenic (★★) | |
| GLA C56Y | 56 | Pathogenic / likely pathogenic (★★) | |
| GLA E66G | 66 | Pathogenic / likely pathogenic (★★) | |
| GLA L89P | 89 | Pathogenic / likely pathogenic (★★) | |
| GLA L89R | 89 | Pathogenic / likely pathogenic (★★) | |
| GLA I91T | 91 | Pathogenic / likely pathogenic (★★) | |
| GLA D92H | 92 | Pathogenic / likely pathogenic (★★) | |
| GLA D92G | 92 | Pathogenic / likely pathogenic (★★) | |
| GLA D92N | 92 | Pathogenic / likely pathogenic (★★) | |
| GLA D93G | 93 | Pathogenic / likely pathogenic (★★) | |
| GLA D93N | 93 | Pathogenic / likely pathogenic (★★) | |
| GLA C94F | 94 | Pathogenic / likely pathogenic (★★) | |
| GLA R112L | 112 | Pathogenic / likely pathogenic (★★) | |
| GLA R112S | 112 | Pathogenic / likely pathogenic (★★) | |
| GLA R112C | 112 | Pathogenic / likely pathogenic (★★) | |
| GLA F113S | 113 | Pathogenic / likely pathogenic (★★) | |
| GLA A121P | 121 | Pathogenic / likely pathogenic (★★) | |
| GLA G138E | 138 | Pathogenic / likely pathogenic (★★) | |
| GLA D155E | 155 | Pathogenic / likely pathogenic (★★) | |
| GLA A156T | 156 | Pathogenic / likely pathogenic (★★) | |
| GLA L167P | 167 | Pathogenic / likely pathogenic (★★) | |
| GLA G171D | 171 | Pathogenic / likely pathogenic (★★) | |
| GLA G171S | 171 | Pathogenic / likely pathogenic (★★) | |
| GLA C172R | 172 | Pathogenic / likely pathogenic (★★) | |
| GLA C172Y | 172 | Pathogenic / likely pathogenic (★★) | |
| GLA G183S | 183 | Pathogenic / likely pathogenic (★★) | |
| GLA G183D | 183 | Pathogenic / likely pathogenic (★★) | |
| GLA M187T | 187 | Pathogenic / likely pathogenic (★★) | |
| GLA C202R | 202 | Pathogenic / likely pathogenic (★★) | |
| GLA C202Y | 202 | Pathogenic / likely pathogenic (★★) | |
| GLA C202W | 202 | Pathogenic / likely pathogenic (★★) | |
| GLA Y207C | 207 | Pathogenic / likely pathogenic (★★) | |
| GLA Y207S | 207 | Pathogenic / likely pathogenic (★★) | |
| GLA I219T | 219 | Pathogenic / likely pathogenic (★★) | |
| GLA C223R | 223 | Pathogenic / likely pathogenic (★★) | |
| GLA C223Y | 223 | Pathogenic / likely pathogenic (★★) | |
| GLA N224D | 224 | Pathogenic / likely pathogenic (★★) | |
| GLA N224T | 224 | Pathogenic / likely pathogenic (★★) | |
| GLA N224S | 224 | Pathogenic / likely pathogenic (★★) | |
| GLA H225D | 225 | Pathogenic / likely pathogenic (★★) | |
| GLA R227P | 227 | Pathogenic / likely pathogenic (★★) | |
| GLA R227Q | 227 | Pathogenic / likely pathogenic (★★) | |
| GLA D234Y | 234 | Pathogenic / likely pathogenic (★★) | |
| GLA W236C | 236 | Pathogenic / likely pathogenic (★★) | |
| GLA W236R | 236 | Pathogenic / likely pathogenic (★★) | |
| GLA Q250P | 250 | Pathogenic / likely pathogenic (★★) | |
| GLA P259R | 259 | Pathogenic / likely pathogenic (★★) | |
| GLA G260R | 260 | Pathogenic / likely pathogenic (★★) | |
| GLA G261V | 261 | Pathogenic / likely pathogenic (★★) | |
| GLA G261D | 261 | Pathogenic / likely pathogenic (★★) |
Showing 60 of 320.
Uncertain variants prioritized for review in Fabry disease
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| GLA A288D | 288 | Conflicting reports (★) | +7: 7 other pathogenic changes within 3 positions; A288P at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.969 | |
| GLA S297C | 297 | Conflicting reports (★) | +7: 12 other pathogenic changes within 3 positions; S297F at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.959 | |
| GLA F159C | 159 | Conflicting reports (★) | +7: 6 other pathogenic changes within 3 positions; F159S at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.969 | |
| GLA D266H | 266 | Conflicting reports (★) | +7: 13 other pathogenic changes within 3 positions; D266Y at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.990 | |
| GLA C63R | 63 | Conflicting reports (★) | +7: 5 other pathogenic changes within 3 positions; C63Y at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.950 | |
| GLA G85V | 85 | Conflicting reports (★) | +7: 4 other pathogenic changes within 3 positions; G85D at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.984 | |
| GLA D266A | 266 | Conflicting reports (★) | +7: 13 other pathogenic changes within 3 positions; D266Y at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.971 | |
| GLA P40A | 40 | Conflicting reports (★) | +7: 10 other pathogenic changes within 3 positions; P40S at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.950 | |
| GLA C56F | 56 | Conflicting reports (★) | +7: 5 other pathogenic changes within 3 positions; C56G at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.961 | |
| GLA G85A | 85 | Conflicting reports (★) | +7: 4 other pathogenic changes within 3 positions; G85D at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.980 | |
| GLA P205A | 205 | Conflicting reports (★) | +7: 8 other pathogenic changes within 3 positions; P205L at the same position is pathogenic; seen in 9e-06 of gnomAD DNA copies; REVEL 0.901 | |
| GLA M267T | 267 | Conflicting reports (★) | +7: 13 other pathogenic changes within 3 positions; M267R at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.923 | |
| GLA D231A | 231 | Conflicting reports (★) | +7: 5 other pathogenic changes within 3 positions; D231N at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.915 | |
| GLA L415R | 415 | Conflicting reports (★) | +7: 4 other pathogenic changes within 3 positions; L415P at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.908 | |
| GLA N320H | 320 | Conflicting reports (★) | +7: 9 other pathogenic changes within 3 positions; N320K at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.911 | |
| GLA A292T | 292 | Conflicting reports (★) | +7: 8 other pathogenic changes within 3 positions; A292V at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.931 | |
| GLA V269E | 269 | Conflicting reports (★) | +7: 14 other pathogenic changes within 3 positions; V269G at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.915 | |
| GLA D299E | 299 | Conflicting reports (★) | +7: 14 other pathogenic changes within 3 positions; D299G at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.840 | |
| GLA M290I | 290 | Conflicting reports (★) | +7: 10 other pathogenic changes within 3 positions; M290T at the same position is pathogenic; seen in 2.7e-06 of gnomAD DNA copies; REVEL 0.884 | |
| GLA H125Y | 125 | Uncertain (★★) | +7: H125L at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.946 | |
| GLA S201P | 201 | Uncertain (★) | +7: 6 other pathogenic changes within 3 positions; S201F at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.970 | |
| GLA F159V | 159 | Uncertain (★) | +7: 6 other pathogenic changes within 3 positions; F159S at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.924 | |
| GLA D234H | 234 | Uncertain (★) | +7: 8 other pathogenic changes within 3 positions; D234Y at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.948 | |
| GLA F159L | 159 | Uncertain (★★) | +7: 6 other pathogenic changes within 3 positions; F159S at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.923 | |
| GLA D264N | 264 | Uncertain (★★) | +7: 15 other pathogenic changes within 3 positions; D264V at the same position is pathogenic; seen in 3.7e-06 of gnomAD DNA copies; REVEL 0.932 | |
| GLA D165N | 165 | Uncertain (★★) | +7: 11 other pathogenic changes within 3 positions; D165H at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.934 | |
| GLA M267V | 267 | Uncertain (★) | +7: 13 other pathogenic changes within 3 positions; M267R at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.947 | |
| GLA G144D | 144 | Uncertain (★★) | +7: 6 other pathogenic changes within 3 positions; G144V at the same position is pathogenic; seen in 1.8e-06 of gnomAD DNA copies; REVEL 0.929 | |
| GLA A257T | 257 | Uncertain (★★) | +7: 7 other pathogenic changes within 3 positions; A257V at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.899 | |
| GLA P214S | 214 | Uncertain (★) | +7: 5 other pathogenic changes within 3 positions; P214L at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.825 | |
| GLA A291S | 291 | Uncertain (★★) | +7: 8 other pathogenic changes within 3 positions; A291T at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.881 | |
| GLA S201A | 201 | Uncertain (★★) | +7: 6 other pathogenic changes within 3 positions; S201F at the same position is pathogenic; seen in 3.7e-06 of gnomAD DNA copies; REVEL 0.939 | |
| GLA M290V | 290 | Uncertain (★★) | +7: 10 other pathogenic changes within 3 positions; M290T at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.894 | |
| GLA T39M | 39 | Uncertain (★★) | +7: 8 other pathogenic changes within 3 positions; T39R at the same position is pathogenic; seen in 8.9e-06 of gnomAD DNA copies; REVEL 0.869 | |
| GLA P389R | 389 | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; P389A at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.713 | |
| GLA I242F | 242 | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; I242N at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.717 | |
| GLA M284I | 284 | Uncertain (★★) | +6: 4 other pathogenic changes within 3 positions; M284T at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.59 | |
| GLA V316A | 316 | Uncertain (★★) | +6: 5 other pathogenic changes within 3 positions; V316E at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.742 | |
| GLA H46Q | 46 | Uncertain (★★) | +6: 12 other pathogenic changes within 3 positions; H46P at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.751 | |
| GLA A143S | 143 | Uncertain (★) | +6: 5 other pathogenic changes within 3 positions; A143P at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.653 |
Diseases related to Fabry disease
- Hypertrophic cardiomyopathy, also linked to GLA
- Primary familial hypertrophic cardiomyopathy, also linked to GLA
Frequently asked questions
Which genes have records linked to Fabry disease?
This view contains 1 analyzed proteins: GLA. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 320 pathogenic or likely pathogenic variants, 198 variants of uncertain significance and 63 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 44 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 625 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center